Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

San Diego Gamma Knife Center: Diagnostic Precision Leads to Treatment Precision for Primary Brain Gliomas

Thanks to better diagnostic procedures and technologies, cases of primary brain tumors are on the rise, but better diagnostic capabilities offer patients and providers greater insight into which treatments will be most effective. Therapies like Gamma Knife™ radiosurgery allow for precise, non-invasive treatment of even difficult to manage brain tumors, like astrocytomas.


News provided by

Joto Extreme PR

Jul 09, 2018, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. John Alksne, Professor of Neurosurgery at University of California, San Diego, discusses the impact of Gamma Knife radiosurgery for people living with glimoas.
Dr. John Alksne, Professor of Neurosurgery at University of California, San Diego, discusses the impact of Gamma Knife radiosurgery for people living with glimoas.

SAN DIEGO, July 9, 2018 /PRNewswire-PRWeb/ -- Last year, over 79,000 new cases of primary brain tumors were diagnosed worldwide (1), with almost 24,000 cases occurring within the United States. (2) Primary brain tumors originate inside the brain itself. Almost 25% of all primary brain tumors are gliomas (1), which develop from glial cells that surround nerves and help them function correctly. (3) But better diagnostic tools are paving the way for more effective treatment options which can begin earlier and are less-invasive compared to more traditional therapies, say experts at the industry leading San Diego Gamma Knife Center®. Better treatment, such as Gamma Knife™ radiosurgery, gives patients hope for better outcomes with minimal side effects.

Brain tumors like gliomas are diagnosed using a combination of microscopic tissue examination and genomic tests. (4) These procedures help doctors identify gliomas and predict how tumors will respond to treatment. But examining tissue samples under a microscope is subjective, and, in many cases, different pathologists provide different opinions as to the nature and stage of a specific brain tumor tissue sample. But new technology, which couples artificial intelligence (AI) with data from tissue biopsies is proving to be more accurate than traditional tumor diagnostic methods. (4)

"Radiosurgery using Gamma Knife™ is a highly-effective treatment option for people living with gliomas. This life-saving treatment offers a relief from brain tumor symptoms and management of the tumor itself."

Post this

This is good news for people living with brain tumors. Out of all gliomas diagnosed worldwide, more than 30% are identified as astrocytomas, a notoriously difficult type of brain cancer to treat as it easily spreads throughout brain tissue. (1) In addition to new diagnostic tools using AI, dynamic contrast material-enhanced (DCE) and dynamic susceptibility contrast magnetic resonance (DSC-MR) are providing doctors with better tumor staging accuracy compared to standard methods. (5)

And better, more accurate diagnosis means more effective treatment can begin sooner. Many people living with astrocytomas are not surgical candidates because their tumors are located deep within normal brain tissue. And for many, other treatment options, like chemotherapy, cause side effects that significantly disrupt normal life. For these patients, and for others searching for a more precision-guided approach to treatment, Gamma Knife™ treatment offers effective management of primary brain tumors, including gliomas like astrocytomas.

Dr. John Alksne, Profession of Neurosurgery at University of California, San Diego and credentialed neurosurgeon with San Diego Gamma Knife Center®, says, "Radiosurgery using Gamma Knife™ is a highly-effective treatment option for people living with gliomas. This life-saving treatment offers a relief from brain tumor symptoms and management of the tumor itself. And compared to other therapies like chemo and surgery, Gamma Knife™ offers more precise treatment in a non-invasive manner, helping spare the patient from many unpleasant side effects and preserving as much healthy tissue as possible."

Gamma Knife™ radiosurgery is generally performed on an outpatient basis, and most patients resume normal activities on the same day as treatment. And compared to other cancer therapies, side effects are generally minimal — headache and fatigue are most commonly reported. (6)

The San Diego Gamma Knife Center® has already helped over 4,000 people manage their brain tumors and lead healthier lives. As the industry leading Gamma Knife™ treatment center in San Diego County, they are primed to provide this life-saving treatment to citizens of California, the United States, and the world.

About San Diego Gamma Knife Center:
Since its opening, the San Diego Gamma Knife Center® has treated over 4,000 patients with various brain disorders from around the world. The facility is equipped to provide advanced radiosurgical treatment for a variety of conditions, including metastatic brain tumors, primary brain tumors, arteriovenous malformations, and functional disorders such as trigeminal neuralgia and cluster headaches.

On the campus of Scripps Memorial Hospital, the Center offers the use of its facilities to some of the top neurosurgeons and radiation oncologists in Southern California. It's also a proud partner of the Neurosciences Department of Scripps Memorial Hospital La Jolla, helping to provide accurate diagnoses, treatment and support for a range of neurological conditions and disorders. To learn more about the San Diego Gamma Knife Center®, please visit http://www.sdgkc.com.

Media Inquiries:
Ash Richardson
JoTo PR
727-777-4625
http://www.JoToPR.com

Sources:
1.    Glioma Diagnosis and Treatment Market Analysis 2018 (By Segment, Key Players and Applications) and Forecasts To 2023. MedGadget. https://www.medgadget.com/2018/05/glioma-diagnosis-and-treatment-market-analysis-2018-by-segment-key-players-and-applications-and-forecasts-to-2023.html. Accessed June 30, 2018.
2.    Brain Tumor: Statistics. American Society of Clinical Oncology. https://www.cancer.net/cancer-types/brain-tumor/statistics. Accessed June 30, 2018.
3.    Glioma. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/glioma/symptoms-causes/syc-20350251. Accessed June 30, 2018.
4.    Paul, Marla. "Machines see the future for patients diagnosed with brain tumors". Northwestern University. https://news.northwestern.edu/stories/2018/march/machines-see-the-future-for-patients-diagnosed-with-brain-tumors/. Accessed June 30, 2018.
5.    Dynamic Contrast-Enhanced, Susceptibility Contrast MR Images Help Grade Gliomas. Diagnostic Imaging. http://www.diagnosticimaging.com/contrast-agents/dynamic-contrast-enhanced-susceptibility-contrast-mr-images-help-grade-gliomas. Accessed June 30, 2018.
6.    Gamma Knife FAQs. San Diego Gamma Knife Center. https://sandiegogammaknife.com/faq/. Accessed June 30, 2018.

SOURCE Joto Extreme PR

Related Links

jotopr.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.